{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:55:08Z","timestamp":1766811308445,"version":"3.48.0"},"reference-count":23,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2025]]},"DOI":"10.3960\/jslrt.25030","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T22:06:41Z","timestamp":1761775601000},"page":"283-290","source":"Crossref","is-referenced-by-count":0,"title":["Triple-hit TdT-positive high-grade B-cell lymphoma mimicking                    B-lymphoblastic lymphoma and exhibiting immunophenotypic change at                    relapse"],"prefix":"10.3960","volume":"65","author":[{"given":"Akio","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Hematology, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Isoda","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"},{"name":"Department of Hematology, Hoshi Iin, Maebashi, Gunma, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirono","family":"Iriuchishima","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"},{"name":"Department of Clinical Research, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Mihara","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Shibukawa Medical Center,                            Shibukawa, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory\u00a0Medicine, Graduate                            School of Medicine, Nagoya University, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bhavsar                            S,                                Liu                            YC,                                Gibson                            SE,                                Moore                            EM,                                Swerdlow                            SH. Mutational                    Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From                    B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive                    Entity. Am J Surg Pathol. 2022; 46: 71-82.","DOI":"10.1097\/PAS.0000000000001750"},{"key":"2","unstructured":"2 Swerdlow SH, Campo E, Harris NL, <i>et                        al.<\/i> (eds): WHO Classification of Tumours of Haematopoietic and                    Lymphoid Tissues. 4th ed, Vol. 2. Lyon, IARC. 2017; pp.                    335-341."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Slot                            LM,                                Hoogeboom                            R,                                Smit                            LA                    <i>et al.<\/i> B-Lymphoblastic Lymphomas Evolving from Follicular                    Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains. Am J                    Pathol. 2016; 186: 3273-3284.","DOI":"10.1016\/j.ajpath.2016.07.027"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Hamdan                            H,                                Luu                            L,                                Opsahl                            M                    <i>et al.<\/i> Genomic profile of TdTpositive MYC\/BCL2 rearranged                    high-grade B-cell lymphoma supporting its diagnosis as mature aggressive                    lymphoma. Cytometry B Clin Cytom. 2022; 102: 448-450.","DOI":"10.1002\/cyto.b.22092"},{"key":"5","unstructured":"5 Khoury JD, Solary E, Abla O, <i>et                        al.<\/i> (eds): WHO Classification of Haematolymphoid Tumours. 5th ed,                    Vol. 1. Lyon, International Agency for Research on Cancer. 2022; pp.                    476-480."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Nie                            K,                                Redmond                            D,                                Eng                            KW                    <i>et al.<\/i> Mutation landscape, clonal evolution pattern, and                    potential pathogenic pathways in B-lymphoblastic transformation of follicular                    lymphoma. Leukemia. 2021; 35: 1203-1208.","DOI":"10.1038\/s41375-020-01014-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ok                            CY,                                Medeiros                            LJ,                                Thakral                            B                    <i>et al.<\/i> High-grade B-cell lymphomas with TdT expression: a                    diagnostic and classification dilemma. Mod Pathol. 2019; 32:                    48-58.","DOI":"10.1038\/s41379-018-0112-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Geyer                            JT,                                Subramaniyam                            S,                                Jiang                            Y                    <i>et al.<\/i> Lymphoblastic transformation of follicular lymphoma: a                    clinicopathologic and molecular analysis of 7 patients. Hum Pathol. 2015; 46:                    260-271.","DOI":"10.1016\/j.humpath.2014.10.021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Rodriguez-Pinilla                            SM,                                Dojcinov                            S,                                Dotlic                            S                    <i>et al.<\/i> Aggressive B-cell non-Hodgkin lymphomas: a report of the                    lymphoma workshop of the 20th meeting of the European Association for                    Haematopathology. Virchows Arch. 2024; 484: 15-29.","DOI":"10.1007\/s00428-023-03579-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Wagener                            R,                                L\u00f3pez                            C,                                Kleinheinz                            K                    <i>et al.<\/i> IG-MYC+ neoplasms with precursor B-cell phenotype are                    molecularly distinct from Burkitt lymphomas. Blood. 2018; 132:                    2280-2285.","DOI":"10.1182\/blood-2018-03-842088"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Liu                            W,                                Hu                            S,                                Konopleva                            M                    <i>et al.<\/i> De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute                    Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients                    Associated With Poor Prognosis. Pediatr Hematol Oncol. 2015; 32:                    535-547.","DOI":"10.3109\/08880018.2015.1087611"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Khanlari                            M,                                Medeiros                            LJ,                                Lin                            P                    <i>et al.<\/i> Blastoid high-grade B-cell lymphoma initially presenting                    in bone marrow: a diagnostic challenge. Mod Pathol. 2022; 35:                    419-426.","DOI":"10.1038\/s41379-021-00909-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Goyal                            G,                                Magnusson                            T,                                Wang                            X                    <i>et al.<\/i> Modern, real-world patterns of care and clinical                    outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with                    or without double\/triple-hit status in the United States. Haematologica. 2023;                    108: 1190-1195.","DOI":"10.3324\/haematol.2022.281461"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Roshal                            M,                                Fromm                            JR,                                Winter                            S,                                Dunsmore                            K,                                Wood                            BL. Immaturity                    associated antigens are lost during induction for T cell lymphoblastic leukemia:                    implications for minimal residual disease detection. Cytometry B Clin Cytom.                    2010; 78: 139-146.","DOI":"10.1002\/cyto.b.20511"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Akiyama                            M,                                Yamada                            O,                                Agawa                            M                    <i>et al.<\/i> Effects of prednisolone on specifically expressed genes                    in pediatric acute B-lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008; 30:                    313-316.","DOI":"10.1097\/MPH.0b013e318161a28f"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Peralta-Zaragoza                            O,                                Recillas-Targa                            F,                                Madrid-Marina                            V. Terminal                    deoxynucleotidyl transferase is down-regulated by AP-1-like regulatory elements                    in human lymphoid cells. Immunology. 2004; 111: 195-203.","DOI":"10.1111\/j.0019-2805.2003.01791.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Trinh                            LA,                                Ferrini                            R,                                Cobb                            BS                    <i>et al.<\/i> Down-regulation of TDT transcription in CD4(+) CD8(+)                    thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes                    Dev. 2001; 15: 1817-1832.","DOI":"10.1101\/gad.905601"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Zeremski                            V,                                Kropf                            S,                                Koehler                            M                    <i>et al.<\/i> Induction treatment in high-grade B-cell lymphoma with a                    concurrent MYC and BCL2 and\/or BCL6 rearrangement: a systematic review and                    meta-analysis. Front Oncol. 2023; 13:                    1188478.","DOI":"10.3389\/fonc.2023.1188478"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Landsburg                            DJ,                                Falkiewicz                            MK,                                Maly                            J                    <i>et al.<\/i> Outcomes of Patients With Double-Hit Lymphoma Who                    Achieve First Complete Remission. J Clin Oncol. 2017; 35:                    2260-2267.","DOI":"10.1200\/JCO.2017.72.2157"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Herrera                            AF,                                Rodig                            SJ,                                Song                            JY                    <i>et al.<\/i> Outcomes after Allogeneic Stem Cell Transplantation in                    Patients with Double-Hit and Double-Expressor Lymphoma. Biol Blood Marrow                    Transplant. 2018; 24: 514-520.","DOI":"10.1016\/j.bbmt.2017.11.023"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Westin                            JR,                                Oluwole                            OO,                                Kersten                            MJ                    <i>et al.<\/i> Survival with Axicabtagene Ciloleucel in Large B-Cell                    Lymphoma. N Engl J Med. 2023; 389: 148-157.","DOI":"10.1056\/NEJMoa2301665"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kamdar                            M,                                Solomon                            SR,                                Arnason                            J                    <i>et al.<\/i> Lisocabtagene maraleucel versus standard of care with                    salvage chemotherapy followed by autologous stem cell transplantation as                    second-line treatment in patients with relapsed or refractory large B-cell                    lymphoma (TRANSFORM): results from an interim analysis of an open-label,                    randomised, phase 3 trial. Lancet. 2022; 399: 2294-2308.","DOI":"10.1016\/S0140-6736(22)00662-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Morschhauser                            F,                                Leung                            W,                                Raghavan                            V                    <i>et al.<\/i> Deciphering the Clinical Benefit of Pola-R-CHP versus                    R-CHOP in Different Genetic Subtypes Beyond Cell of Origin in the POLARIX Study.                    Blood. 2023; 142: 3000.","DOI":"10.1182\/blood-2023-178623"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25030\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:41:41Z","timestamp":1766810501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25030\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25030","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25030"}}